Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Sanofi 2 ADR Representing Ord Shs SNY

Healthcare
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SNY)

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024

GlobeNewswire 4 days ago

Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy

GlobeNewswire 4 days ago

Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)

GlobeNewswire 4 days ago

Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines

PR Newswire 7 days ago

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

GlobeNewswire January 25, 2024

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

PR Newswire January 23, 2024

Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment

Business Wire November 30, 2023

Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease

GlobeNewswire November 27, 2023

Sanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities

PR Newswire November 2, 2023
View More News ››

Opinion & Analysis (NDAQ:SNY)

Translate Bio and Sanofi Expand Partnership to Develop mRNA Vaccines

Streetwise Reports June 24, 2020

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Streetwise Reports September 24, 2019
View More Opinion ››

Bullboard Posts (NDAQ:SNY)

Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sal

Breaking News: $SNY Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings | BenzingaThursday,@Sanofi SA@...
whytestocks - April 25, 2024

Sanofi and Covid19? WPD Pharma...

Sanofi could easily buy WPD Pharma, who develop a Covid19-drug called WP1122. Did you read this? https://www.globenewswire.com/news...
Blocky - January 8, 2021

Happy new year Do your Own DD

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
Rossaporino - January 2, 2021

Bonvoyage12.....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Vaccine Stocks - Can the President Overrule the FDA?

An approval cycle that typically takes years is being expedited. In the case of the 2020 pandemic, the FDA  has shortened standard...
schoolofrock - October 7, 2020

Room to run?

Tough market these days but.... Hydroxyquinoline for potential covid co-treatment And now the vaccine deal... Seems promising ...
Gbathat - March 27, 2020
View more Bullboard ››

Eastern Platinum Ltd.

Eastern Platinum Ltd.

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the ...
View More »